Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab-Based Chemoimmunotherapy in Untreated CLL/SLL
NCT01145209Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jul 2010
- Primary completion
- Oct 2017
- Countries
- 1
01
Overview
A Phase 2 trial of ofatumumab in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), sponsored by National Heart, Lung, and Blood Institute. Started Jul 2010; status: completed.
02
Drugs
ofatumumab
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT01145209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01145209.